Haemorheological use of N-alkylated 1,4-dihydropyridine-dicarboxylic acid esters, and some new compounds
US5432185A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | May 21, 1993 |
| Grant date | Jul 11, 1995 |
| Priority date | — |
| Expiry date | May 21, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Improving circulation, with minimal effect on blood pressure, using N-alkylated 1,4-dihydropyridines of the formula ##STR1## in which R.sup.1 represents hydrogen, nitro, cyano, trifluoromethyl, trifluoromethoxy, halogen or methyl, PA1 R.sup.2 represents hydrogen, halogen, nitro, hydroxyl, trifluoromethyl or methyl, PA1 R.sup.3 represents hydrogen or cyano, or PA1 R.sup.2 and R.sup.3 together form a fused benzo ring, PA1 R.sup.4 and R.sup.5 are identical or different and represent straight-chain or branched alkyl having up to 8 carbon atoms, which is optionally substituted by alkoxy having up to 4 carbon atoms, and PA1 R.sup.6 represents straight-chain or branched alkyl having up to 10 carbon atoms or represents cycloalkyl having 3 to 7 carbon atoms. Many of the compounds are new.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.